A new test shows that the Russian COVID-19 vaccine may still be effective.
In an article published in the medical journal Lancet, Russian researchers discovered that the vaccine induces an antibody reaction and a reaction on T-phones, a type of white blood cell phone that is helping to fight the infection, and caused serious side effects.
The vaccine was tested in two Russian hospitals among 76 patients, however, there are limits for research.It has only been tested in patients between the age of 18 and 60, leaving open the question of whether it will be a picture for the elderly, who are at maximum risk of dying from COVID-19.The trial also did not use placebo. And there were only men who volunteered.
In August, the Russian government approved the vaccine before moving on to Phase 3 trials, a resolution that generated strong complaints from fitness officials around the world.
“Russia has answered questions about this,” kirill Dmitriev, executive director of the vaccine-supported Russian Direct Investment Fund, said in a convening of the convention.”And we are convinced that we have the vaccine in the world..”
In the United States, President Trump legalized “Operation Warp Speed,” an initiative to administer three hundred million doses of an effective vaccine through January.Some critics have accused the administration of putting politics before counterfeit science.